Genetic testing for GLP-1 response isnt part of any prescribing guideline, and the consumer product based on this research hasnt been validated in a clinical trial
[1] [4] Wegovy, a higher-dose subcutaneous semaglutide formulation, received FDA approval for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia
Beta blockers act to block the action of endogenous catecholamines epinephrine (adrenaline) and norepinephrine (noradrenaline), which mediates the fight-or-flight response
It wouldnt be surprising to see Trump scuttle the plan to cover weight loss drugs, given the incoming administrations desire to slash the federal budget and regulations, as well as potential HHS Secretary Robert F
However, extreme caloric restriction or excessive weight loss can potentially disrupt hormonal balance in both sexes, potentially leading to relative energy deficiency in sport (RED-S) or hypothalamic dysfunction
